Yanela Margarita Duenas Milian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-3311 Fax: 804-443-6150 |
Angelina Maneval, D.O. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-3311 Fax: 804-443-6051 |
John A. Michos, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 659 Hospital Rd, A-101, Tappahannock, VA 22560 Phone: 804-443-9379 |
Bruce Myron Bucher, MD MPH SCD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 721 Charlotte St., Tappahannock, VA 22560 Phone: 804-443-5378 Fax: 804-443-9667 |
Dr. Robert Macintyre Bennett, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 658 Hospital Rd, Suite 302, Tappahannock, VA 22560 Phone: 804-443-6235 Fax: 804-443-6239 |
Hani Nazha, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 618 Hospital Rd, Tappahannock, VA 22560 Phone: 804-443-6282 Fax: 804-443-6051 |
News Archive
"Counterfeit medications are a serious and sometimes deadly problem in developing countries," but "two teams of U.S.-based scientists have developed quick tests can identify counterfeit drugs before they can cause harm," VOA News reports.
WHO representative Guido Sabatinelli has assured Pakistan health officials that the organization "will be scaling up its humanitarian response in all the flood-affected areas of Sindh to resolve health issues faced by the displaced people," News International reports.
Men with prostate cancer generally make treatment decisions based on differences in the information they receive rather than their own preferences, according to a new review.
For the first time, researchers have determined that a brief, simple number naming test can differentiate between cognitively healthy elderly individuals and cognitively impaired people with Alzheimer's disease (AD), including those with mild cognitive impairment (MCI), as well as those with AD dementia.
Hillenbrand reported net revenues of $153.1 million for the fourth quarter of 2009, which ended Sept. 30, 2009, a $5.7 million (3.6 percent) decline from the same period in fiscal 2008. The company posted net income of $22.6 million, a $3.4 million (17.7 percent) increase from last year.
› Verified 3 days ago